Currently, there are 77.23M common shares owned by the public and among those 54.45M shares have been available to trade.
Insiders at the company have transacted a total of 16 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 8 of these insider trades were purchases, accounting for 2,012,375 shares. Insider sales of the common stock occurred on 8 occasions, with total insider shares sold totaling 2,311,284 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 5.83, up 43.47%. The company’s stock has a 5-day price change of 93.53% and 152.58% over the past three months. APLT shares are trading 60.60% year to date (YTD), with the 12-month market performance up to 438.00% higher. It has a 12-month low price of $0.76 and touched a high of $4.42 over the same period. APLT has an average intraday trading volume of 1.57 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 84.94%, 86.51%, and 160.61% respectively.
Institutional ownership of Applied Therapeutics Inc (NASDAQ: APLT) shares accounts for 71.39% of the company’s 77.23M shares outstanding.
It has a market capitalization of $415.50M and a beta (3y monthly) value of 1.55. The earnings-per-share (ttm) stands at -$1.32. Price movements for the stock have been influenced by the stock’s volatility, which stands at 22.66% over the week and 12.74% over the month.
Analysts forecast that Applied Therapeutics Inc (APLT) will achieve an EPS of $Apellis Pharmaceuticals, Inc. for the current quarter, $68.78 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Applied Digital Corporation while analysts give the company a high EPS estimate of $Applied Therapeutics, Inc.. Comparatively, EPS for the current quarter was $Ault Alliance, Inc. a year ago. Earnings per share for the fiscal year are expected to increase by 28.98%, and 46.48% over the next financial year.
Looking at the support for the APLT, a number of firms have released research notes about the stock. Barclays stated their Equal Weight rating for the stock in a research note on January 04, 2022, with the firm’s price target at $44-$7.
